Encephalomyelitis and Medical Marijuana: Types and Research
Encephalomyelitis means inflammation of both the brain and the spinal cord, and the same word is used for several different diseases: acute disseminated encephalomyelitis (ADEM), myalgic encephalomyelitis (ME/CFS), an old name for multiple sclerosis, rare autoimmune forms and a laboratory model called EAE. For medical marijuana the evidence is narrow. In animal and cell studies of that lab model, cannabinoids such as CBD and THC softened signs of inflammation, but none of the research behind this page tested people with any form of encephalomyelitis.
Based on peer-reviewed laboratory studies in animals and cells; every study is listed below
After ADEM, living with ME/CFS, or told it might be MS: where to start
Brain fog that will not lift. Legs that feel heavy by midafternoon. A crash that lasts two days after a short walk to the mailbox. And three doctors who wrote three different names on three different forms. People land on the word encephalomyelitis after months of tests, often while the people around them see someone who looks fine.
Part of the confusion is the word itself, which points to very different illnesses. Part of it is cannabis: the questions about it come wrapped in stigma, and the research is easy to over-read. Pick the line that sounds like you and start there; the rest of this guide sorts the types, the evidence and the conversation with your physician.
I was treated for ADEM
You or your child had a hospital stay, steroids, maybe IVIG. The questions now are recovery, relapse and what is safe to add.
I live with ME/CFS
Exhaustion after effort, sleep that does not restore. None of the cannabis studies cited here looked at ME/CFS, and the page says so plainly.
A doctor mentioned MS
Encephalomyelitis disseminata is an older name for multiple sclerosis, and MS is where cannabis has actually been studied in people.
I already use cannabis
Then the useful questions are about your other medicines, the form you use and what to tell your neurologist.
What is encephalomyelitis? Definition, pronunciation and ICD-10 codes
Encephalomyelitis is inflammation of the brain and the spinal cord at the same time. The inflammation can be triggered by an infection, by the immune system attacking the coating of nerve fibers (myelin), or, rarely, by a reaction after a vaccine. Symptoms depend on where the inflamed areas sit: confusion, weakness, numbness, problems with balance or vision [2].
The word, broken down
- encephalo-brain
- myel-spinal cord
- -itisinflammation
How to pronounce encephalomyelitis
en-SEF-uh-loh-MY-uh-LY-tis (stress on SEF and LY)
ICD-10 codes for encephalomyelitis
There is no single code for encephalomyelitis. In the United States the code on your record depends on which disease was diagnosed. The multiple sclerosis code changed recently: since October 2025 the old single code G35 is split by course of the disease [3].
| Code | What it covers | Type |
|---|---|---|
| G04.00 | Acute disseminated encephalitis and encephalomyelitis, unspecified | ADEM |
| G04.01 | Postinfectious acute disseminated encephalitis and encephalomyelitis | ADEM after an infection |
| G04.02 | Postimmunization acute disseminated encephalitis, myelitis and encephalomyelitis | ADEM after a vaccine |
| G04.81 | Other encephalitis and encephalomyelitis | Other named forms |
| G04.90 | Encephalitis and encephalomyelitis, unspecified | Cause not stated |
| G93.32 | Myalgic encephalomyelitis/chronic fatigue syndrome | ME/CFS |
| G35.A to G35.D | Multiple sclerosis: relapsing-remitting, primary progressive, secondary progressive, unspecified | MS (encephalomyelitis disseminata) |
Which encephalomyelitis do you mean? ADEM, ME/CFS, MS, autoimmune and lab EAE compared
Seven different things travel under this one word, and they have little in common beyond the name. Pick the one written on your paperwork; each panel says who gets it, how it runs, how it is treated and whether anyone has studied cannabis for it.
Acute disseminated encephalomyelitis (ADEM)
- Who it affects
- Mostly children, adults less often, usually days to weeks after a viral or bacterial infection and rarely after a vaccine.
- How it runs
- One sudden attack with fever, confusion and widespread inflammation of myelin; most people recover over weeks to months, some relapse.
- Main treatment
- High-dose steroids in hospital, then IVIG or plasma exchange if needed [1].
- Cannabis research
- No studies in people with ADEM.
Myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS)
- Who it affects
- Adults and teenagers of any background, often after an infection; women more often than men.
- How it runs
- Long-lasting, often for years, with good and bad stretches; symptoms get worse after physical or mental effort [4].
- Main treatment
- No approved cure; care manages symptoms: pacing activity, sleep, dizziness on standing, pain.
- Cannabis research
- No studies in people with ME/CFS among those cited here.
Encephalomyelitis disseminata (multiple sclerosis)
- Who it affects
- Mostly adults between 20 and 50 [5]; “encephalomyelitis disseminata” is an older European name for MS.
- How it runs
- Lifelong, most often in relapses and remissions, sometimes steadily progressive [5].
- Main treatment
- Disease-modifying therapies, steroids for relapses, rehabilitation and symptom care.
- Cannabis research
- Human studies exist, mainly on spasticity and pain.
Autoimmune encephalomyelitis (MOGAD, NMOSD)
- Who it affects
- Children and adults whose blood carries antibodies against MOG (MOGAD) or aquaporin-4 (NMOSD).
- How it runs
- Attacks on the optic nerves, spinal cord or brain; can return, so long-term prevention matters.
- Main treatment
- Steroids and plasma exchange for attacks, immune-suppressing drugs to prevent new ones.
- Cannabis research
- No studies in people.
Paraneoplastic encephalomyelitis
- Who it affects
- Adults with a cancer, often not yet found, that makes the immune system attack the nervous system.
- How it runs
- Develops over weeks to months; can come before the cancer is diagnosed.
- Main treatment
- Finding and treating the cancer, plus immune therapy.
- Cannabis research
- No studies in people.
Progressive encephalomyelitis with rigidity and myoclonus (PERM)
- Who it affects
- Rare; adults, often with antibodies against the glycine receptor. It belongs to the stiff person spectrum.
- How it runs
- Muscle stiffness, painful spasms, sudden jerks (myoclonus) and brainstem symptoms that build up over weeks.
- Main treatment
- Immune therapy and medicines that relax muscles and calm spasms.
- Cannabis research
- No studies in people.
Experimental autoimmune encephalomyelitis (EAE)
- Who it affects
- Laboratory mice and rats only. No person has EAE.
- How it runs
- Researchers trigger it with a myelin protein fragment; it is used as a model of MS.
- Main treatment
- Not applicable: it exists to test ideas.
- Cannabis research
- Animal model only. Every cannabis study on this page used it.
Show all types as a table
| Type | Who | Course | Main treatment | Cannabis data |
|---|---|---|---|---|
| ADEM | Mostly children, after infection | One attack, usually recovery | Steroids, IVIG, plasma exchange | None in people |
| ME/CFS | Teens and adults, often after infection | Chronic, fluctuating | Symptom care, pacing | None in people |
| MS (disseminata) | Adults 20 to 50 [5] | Lifelong, relapsing or progressive | Disease-modifying therapy | Human studies exist |
| Autoimmune (MOGAD, NMOSD) | Children and adults with antibodies | Attacks, may return | Steroids, immune therapy | None in people |
| Paraneoplastic | Adults with a cancer | Weeks to months | Treat the cancer, immune therapy | None in people |
| PERM | Rare, adults | Builds over weeks | Immune therapy, muscle relaxants | None in people |
| EAE | Lab mice and rats | Induced in the lab | Not applicable | Animal studies only |
Encephalomyelitis in horses, dogs and birds: a different disease
Equine encephalomyelitis (eastern, western and Venezuelan, shortened to EEE, WEE and VEE) is caused by viruses that mosquitoes carry, and the eastern type can infect people too [6]. Horses are vaccinated against it, often with combination shots that also cover rhinopneumonitis and influenza; which vaccine and when is a question for your veterinarian. Dogs can develop encephalomyelitis from distemper, and avian encephalomyelitis is a viral disease of young poultry.
None of this has anything to do with medical cannabis for people. Cannabis is not a treatment for animals, and THC is toxic to dogs: wobbliness, drooling and urine leakage after a dog gets into an edible need a call to a vet or an animal poison line [7].
Myalgic encephalomyelitis (ME/CFS): what it is, why it’s called that and how long it lasts
Myalgic encephalomyelitis, also called chronic fatigue syndrome or ME/CFS, is a long-term illness that affects many body systems at once. Its signature is post-exertional malaise (PEM): symptoms get worse after physical or mental effort, often a day later, and the crash can last days [4].
What happens in ME/CFS
Besides PEM, the core features named in the 2015 diagnostic criteria are sleep that does not refresh, problems with thinking and memory (brain fog), and dizziness or a racing heart when standing up, called orthostatic intolerance [8]. Pain in muscles and joints is common. Many people are housebound at their worst.
Why it’s called that
“Myalgic” means muscle pain and “encephalomyelitis” was the guess, decades ago, that the brain and spinal cord were inflamed. That inflammation has never been shown consistently, which is why the name chronic fatigue syndrome came into use and why the two now travel together. The WHO classifies it as a neurological disease, and the US code is G93.32 [3].
How long does myalgic encephalomyelitis last?
Usually for years. It tends to move in waves, with better and worse months, and some people improve a great deal while full recovery is uncommon in adults [4]. ME/CFS is not contagious and is not known to shorten life by itself; in the United States it can be the basis of a disability claim when it stops a person from working. Care focuses on pacing activity to stay below the crash point, treating sleep, pain and orthostatic symptoms, and adjusting work and school.
Encephalomyelitis vs encephalitis: what is the difference?
Encephalitis is inflammation of the brain alone; encephalomyelitis is inflammation of the brain and the spinal cord together. Myelitis, the third relative, involves only the spinal cord. Doctors often file them under one heading, which is why the US code group G04 is titled “encephalitis, myelitis and encephalomyelitis” [3].
Encephalomyelitis: the brain and the spinal cord are inflamed.
| Encephalitis | Myelitis | Encephalomyelitis | |
|---|---|---|---|
| What is inflamed | Brain | Spinal cord | Brain and spinal cord |
| Typical causes | Viruses (herpes, mosquito-borne), autoimmune antibodies | Infections, MS, NMOSD, MOGAD | Immune reaction after infection (ADEM), autoimmune disease |
| Typical symptoms | Fever, headache, confusion, seizures | Leg weakness, numbness below a level, bladder problems | A mix of both, often with balance and vision problems |
What causes encephalomyelitis? Infections, rare vaccine reactions and autoimmunity
Most encephalomyelitis is the immune system overreacting, usually after an infection; the cause depends on the type [1].
ADEM
Follows a viral or bacterial infection by days to weeks, more often in children. Rarely it follows a vaccine, which has its own code, G04.02 [3]. Often no trigger is found.
Autoimmune forms
Antibodies against MOG or aquaporin-4 attack myelin or supporting cells. In paraneoplastic forms, the immune response to a hidden cancer turns on the nervous system.
ME/CFS
Often starts after an infection, including COVID-19, though some people cannot name a trigger. Why it persists is still being researched [4].
Encephalomyelitis symptoms: ADEM, ME/CFS and MS side by side
ADEM comes on suddenly with fever and confusion, ME/CFS builds into long-lasting exhaustion that worsens after effort, and MS (encephalomyelitis disseminata) comes in episodes of numbness, weakness or blurred vision. Choose one type to read its column alone.
| Area | ADEM | ME/CFS | MS |
|---|---|---|---|
| How it starts | Over hours to days, often after an infection | Often after an infection, then does not resolve | An episode over days, then partial or full recovery |
| Core symptoms | Fever, headache, vomiting, drowsiness | Crash after effort (PEM), unrefreshing sleep | Fatigue, numbness or tingling, weakness |
| Thinking and mood | Confusion, irritability, in severe cases coma | Brain fog, slow processing, poor memory | Slowed thinking, low mood |
| Movement and feeling | Unsteady walking (ataxia), weakness, numbness | Muscle and joint pain, heavy limbs | Stiffness and spasms, balance problems |
| Vision | Blurred or lost vision from optic nerve inflammation | Light sensitivity, trouble focusing | Painful blurred vision in one eye (optic neuritis) |
| Course | Usually one attack | Chronic, in waves | Lifelong, relapsing or progressive |
The split that matters most is acute against chronic. A sudden change over hours or days, with fever, confusion, a seizure or new loss of vision, is an emergency and belongs in hospital. Symptoms that have been with you for months are a matter for planned care: a neurologist, a diagnosis that holds up, and a plan for the symptoms that bother you most.
Is my kind of encephalomyelitis one where cannabis is even worth asking about?
Twelve short questions about your diagnosis, how you feel right now and the medicines you take. You get a plain reading of what your answers point to, what research has and has not shown for that situation, and what to bring to a physician. This is not a diagnosis.
12 questions · about a minute · your answers stay in this browser
How is encephalomyelitis diagnosed? MRI, spinal tap, antibody tests and what else it could be
There is no single test. Physicians put together a brain and spine MRI, a spinal fluid sample and blood antibody tests, and rule out infection, which together tell ADEM, MS, MOGAD, NMOSD and infectious encephalitis apart [1]. ME/CFS is the exception: it is diagnosed from symptoms against set criteria, because no scan or lab test confirms it [8].
MRI
Shows where the inflammation sits. Many large, similar-age patches suggest ADEM; scattered older and newer spots suggest MS.
Lumbar puncture
A sample of spinal fluid (CSF) checks for infection, extra white cells and oligoclonal bands, which point toward MS.
Antibody blood tests
MOG-IgG and AQP4-IgG identify MOGAD and NMOSD, which are treated differently from MS.
EEG
Records the brain’s electrical activity when there is confusion or a seizure, and shows whether seizures continue unseen.
ME/CFS criteria
The 2015 criteria ask for reduced activity for six months or more, PEM, unrefreshing sleep, plus brain fog or orthostatic intolerance [8].
Reading your MRI report
Reports are written for other doctors. Open the terms you see on yours.
Demyelination
Damage to myelin, the fatty coating that lets nerve signals travel fast. It is the shared feature of ADEM, MS and the antibody diseases.
T2 or FLAIR hyperintensities
Bright spots on two common MRI settings. They mark tissue with extra water, from inflammation, old scarring or, in older adults, small vessel changes. Location and shape matter more than the brightness.
Gadolinium enhancement
Spots that light up after contrast dye are active right now, because the barrier around blood vessels is leaking. Non-enhancing spots are older.
Lesion
Any area that looks different from healthy tissue. The word alone does not say how serious it is.
White matter and gray matter
White matter is the wiring, rich in myelin; gray matter holds the nerve cell bodies. ADEM often touches both, including deep gray matter such as the thalamus.
Oligoclonal bands
A spinal fluid finding, not an MRI one, but it appears in the same reports: antibody bands made inside the nervous system. Common in MS, less so in ADEM.
What else it could be
The main question after a first attack is whether it was a one-time ADEM or the start of something that returns. A first MS attack, MOGAD and NMOSD can all look like ADEM at the start; the antibody tests and a repeat MRI months later usually settle it. Infectious encephalitis, especially herpes, is ruled out early because it needs antiviral treatment right away. For long-lasting fatigue, thyroid disease, anemia, sleep apnea and depression are checked before ME/CFS is diagnosed.
How is encephalomyelitis treated? Steroids, IVIG, plasma exchange and symptom care
Acute encephalomyelitis is treated by calming the immune attack quickly, in hospital. For ADEM the usual sequence is [1]:
- High-dose steroids through a vein, usually methylprednisolone for several days, often followed by a tapering course of tablets.
- IVIG, antibodies pooled from donors, when steroids are not enough or cannot be used.
- Plasma exchange, which filters harmful antibodies out of the blood, for severe attacks that do not respond.
- Rehabilitation: physical, occupational and speech therapy while the nervous system recovers.
Multiple sclerosis is managed for the long term with disease-modifying therapies that reduce relapses, plus treatment of spasticity, bladder symptoms, pain and fatigue; the evidence on cannabis for those symptoms is on cannabis and multiple sclerosis. Antibody diseases such as MOGAD and NMOSD often need long-term immune therapy to prevent new attacks.
ME/CFS has no approved cure, so care is about symptoms: pacing energy to avoid crashes, improving sleep, treating dizziness on standing with fluids, salt or medicines, and managing pain [4]. Graded exercise that pushes through PEM is no longer recommended.
Encephalomyelitis prognosis: recovery, relapse and life after the acute phase
The outlook depends almost entirely on the type: ADEM usually ends in good recovery, MS is lifelong, and ME/CFS tends to last years with ups and downs.
After ADEM
Most children recover fully or nearly fully over weeks to months; adults recover more slowly [1]. A minority have another attack (multiphasic ADEM) or later turn out to have MS or MOGAD, which is why follow-up MRIs matter.
Encephalomyelitis disseminata (MS)
A lifelong condition whose course varies widely between people. Modern treatment has changed the outlook a great deal; the details are on our MS page.
ME/CFS
Long-lasting and fluctuating. Some people improve substantially, especially with early pacing; others stay limited for years. It is not considered progressive in the way MS can be.
Support does not have to come only from the clinic. Patient organizations publish plain-language guides and run support groups: Encephalitis International for encephalitis and ADEM [9], the National Multiple Sclerosis Society for MS [5], and the CDC’s ME/CFS pages for patients and families [4].
Why researchers test cannabinoids in encephalomyelitis models: CB1, CB2 and immune cells
Researchers test cannabinoids here because the body’s own cannabinoid system sits on both sides of the problem: on nerve cells that are damaged and on the immune cells that do the damage. The endocannabinoid system is a set of signaling molecules the body makes itself, the receptors they bind to, and the enzymes that break them down. THC and CBD from the plant act on parts of the same system.
CB1: mostly on nerve cells
CB1 receptors are dense in the brain and spinal cord. In mice with the lab disease, losing CB1 changed how much IFN-gamma, an inflammatory signal, different cells produced, and the effect pointed in different directions depending on the cell type [10].
CB2: mostly on immune cells
CB2 sits on immune cells and on microglia, the brain’s own immune cells. In mice, switching CB2 on with a selective drug reduced Th17 cells, a type of inflammatory T cell, and fewer immune cells built up in the brain and spinal cord [11].
Almost all of this work uses EAE, experimental autoimmune encephalomyelitis. Researchers inject mice or rats with a fragment of a myelin protein, the animal’s immune system attacks its own myelin, and the animal develops weakness and paralysis that is scored on a simple scale. It is used as a model of multiple sclerosis because it reproduces the immune attack on myelin, not because people get it.
The compounds tested include CBD alone, THC and CBD together, a modified form of cannabigerol (CBG) called VCE-003, and drugs that act on CB2 only. Palmitoylethanolamide (PEA) turns up as well; it is a fat-like molecule the body makes that behaves like an endocannabinoid, not a cannabis compound, and it is kept separate below.
What the research shows, from strongest to weakest: animal and cell studies, no human trials
Every study on cannabinoids and encephalomyelitis cited here was done in animals or in cells, and none tested people. Evidence is usually ranked from pooled analyses of trials at the top down to laboratory work at the bottom; for this condition, only the bottom step is occupied.
- Systematic reviews and meta-analysesNone for encephalomyelitis
- Randomized trials in peopleNone for encephalomyelitis
- Observational studies in peopleNone for encephalomyelitis
- Case reportsNone for encephalomyelitis
- Animal and cell studiesEvery study on this page
The lab results lean positive: in most of them, animals given a cannabinoid had milder disease than untreated animals. Read that as a reason to run human trials, which have not been done for ADEM, ME/CFS or autoimmune encephalomyelitis.
Browse the studies
Not every study here tested cannabis. Filter by what was given to the animals; the ones marked as other substances touch the cannabinoid system but are not cannabis products.
Oral CBD and the early immune response
Mice received 75 mg/kg of CBD by mouth for 5 days after the disease was triggered and were followed for 18 days [12]. CBD reduced disease severity, which went together with an early drop in IFN-gamma producing CD8+ T cells in the spleen and a modest reduction of inflammation in the nervous system.
CBD and gene activity in attacking T cells
In T cells from mice with EAE, CBD at 10 mg/kg changed chemical marks on DNA packaging and small regulatory RNAs [13]. It suppressed 74 microRNAs that the disease had switched on and restored 23 that it had switched off [13].
THC and CBD together, and the gut
A 1:1 combination of THC and CBD, 10 mg/kg each by injection, made the disease milder [14]. The treated mice had fewer mucus-degrading gut bacteria, less bacterial toxin reaching the brain and lower levels of inflammatory signals (IL-17A, IFN-gamma).
A 1% CBD cream on the skin
Daily 1% CBD cream rubbed on the hind limbs lowered the average disease score from 5.0 in untreated mice to 1.5 over 28 days [15]. A result in mice with a specific lab cream, not a finding about creams sold to people.
VCE-003, a modified cannabigerol
This lab-made derivative of CBG, given at 5 mg/kg a day by injection, acted through CB2 and PPAR-gamma receptors, damped T cell growth and inflammatory signals, and protected the mice from the disease [16].
The CB1 receptor and IFN-gamma: a mixed result
Mice without CB1 made more IFN-gamma in some immune cells during EAE but less in T cells stimulated directly. The receptor’s role depends on the cell, so blocking or boosting it is not simply good or bad.
A drug that switches on CB2 only
The selective CB2 agonist Gp1a reduced inflammatory Th17 cells outside the nervous system and limited how many immune cells reached the brain and spinal cord, making the disease milder.
Exercise and royal jelly, not cannabis
Five weeks of endurance training plus royal jelly at 50 or 100 mg/kg raised CB1 receptor activity in the hippocampus and the pain threshold in rats with EAE [17]. Included because it measured the cannabinoid system; nothing cannabis-based was given.
Crotalphine, a snake venom peptide
This peptide eased pain and nerve inflammation in mice, partly by activating CB2 receptors and releasing the body’s own opioids. A different substance that happens to use a cannabinoid receptor.
PEA with luteolin
A combination of palmitoylethanolamide, an endocannabinoid-like molecule, and the plant compound luteolin lowered disease scores and inflammation markers in mice. Not a cannabis product.
A microRNA that drives brain inflammation
Mice lacking the regulator Mir223 had milder EAE because their microglia cleared debris more actively. A study of immune wiring with no cannabinoid treatment at all.
No studies in that group.
When were these studies published?
How to read it: each dot is one study, stacked above the year it was published. Dark filled dots tested a cannabis compound, lighter filled dots studied a cannabinoid receptor, and hollow gray dots tested another substance.
The cannabis-compound studies span 2014 to 2021 [16] [12], and the most recent work in this set, from 2022, did not test cannabis at all [17].
Show as a table
| Year | What was tested | Group |
|---|---|---|
| 2014 | VCE-003, modified CBG [16] | Cannabis compound |
| 2014 | Selective CB2 agonist [11] | Receptor study |
| 2015 | 1% CBD cream [15] | Cannabis compound |
| 2019 | CBD and T cell genes [13] | Cannabis compound |
| 2019 | THC and CBD 1:1 [14] | Cannabis compound |
| 2019 | PEA with luteolin [19] | Other substance |
| 2019 | Mir223 deletion [20] | Other substance |
| 2021 | Oral CBD [12] | Cannabis compound |
| 2021 | CB1 receptor deletion [10] | Receptor study |
| 2021 | Crotalphine [18] | Other substance |
| 2022 | Exercise and royal jelly [17] | Other substance |
→ Cannabis and multiple sclerosis, where studies in people exist
What the lab studies did: doses, models and what changed in the animals
In the clearest result, mice treated with a CBD cream ended with a far lower disease score than untreated mice. None of these studies measured how much a person’s symptoms change, so every number below describes animals.
| What was given | Animal | Route | How long | Study |
|---|---|---|---|---|
| CBD 75 mg/kg | Mice | By mouth | 5 days, followed for 18 | 2021 [12] |
| CBD 10 mg/kg | Mice | Injection | Cells collected at day 7 | 2019 [13] |
| THC 10 mg/kg plus CBD 10 mg/kg (1:1) | Mice | Injection | During the disease course | 2019 [14] |
| 1% CBD cream | Mice | On the skin | Daily, 28 days | 2015 [15] |
| VCE-003 (modified CBG) 5 mg/kg a day | Mice | Injection | Daily during disease | 2014 [16] |
Two things stand out. The doses are measured per kilogram of a mouse and mostly injected into the belly, which says nothing about a tincture or a gummy taken by a person. And the products were purified compounds, not plant extracts from a dispensary, where THC and CBD content varies between batches.
Results were not all positive: the negative and mixed studies
The CB1 study is the clearest warning against a simple story. Removing the receptor raised the inflammatory signal IFN-gamma in some immune cells and lowered it in others [10]. Acting on the cannabinoid system can push inflammation in either direction depending on the cell, the receptor and the timing.
Beyond that, the wider literature contains lab studies where cannabinoids did not help or made no clear difference. Positive results in animals are published more readily than negative ones, a pattern called publication bias, so a stack of positive mouse papers looks stronger than it is.
Animal work also has built-in limits. Most of these experiments tested a single dose, in young animals, in a form of EAE that strikes once and then settles. Human encephalomyelitis is usually a different disease, in older bodies, lasting months or years, and drugs that worked in EAE have often failed in people.
What science doesn’t know yet about cannabis and encephalomyelitis
The open questions here are larger than the findings, and most of them come straight from the study authors.
- Whether it does anything in people. No study cited here included a person with ADEM, ME/CFS, autoimmune or paraneoplastic encephalomyelitis.
- Whether the model fits. The common form of EAE strikes once and settles, while chronic progressive MS does not, which limits how far results carry over [19].
- What dose, for how long. Several experiments tested one dose only, with no data on long-term toxicity or on translating animal doses to people [12].
- Whether damaged myelin repairs. Genes linked to repair moved, but myelin proteins themselves did not change measurably in the animals [19].
- How the effect works in detail. Authors list cell types and pathways they could not pin down [10] [13].
- Side effects and interactions in this population. None of these studies recorded them in people, because none involved people.
- Children. ADEM is most common in children, and there is no research on cannabinoids for it at any age.
Is cannabis safe with encephalomyelitis? Balance, brain fog, seizures and who should avoid it
Nobody has measured cannabis safety in people with encephalomyelitis: the studies on this page involved animals only. What is known comes from the prescription labels of cannabinoid medicines and from general use, and several of those effects land on exactly the symptoms this condition causes.
- Balance and falls. THC can cause dizziness and unsteadiness [21]. With ataxia or weak legs after ADEM or in MS, that adds to an existing fall risk.
- Brain fog. THC slows attention and short-term memory [21]. For someone already struggling to think clearly, it can feel like the illness got worse.
- Drowsiness. CBD and THC both cause sleepiness, more so with other sedating medicines [22].
- Heart rate and standing up. THC can raise the heart rate and drop blood pressure on standing [21], which overlaps with the orthostatic intolerance of ME/CFS.
- Liver. Prescription CBD can raise liver enzymes, especially with valproate, so blood tests are part of using it [22].
- Seizures. Prescription CBD is approved for certain rare epilepsies [22], but that does not make plant products safe for seizures after encephalitis; mixed THC products have not been tested for that and seizure medicines interact with CBD.
Cannabis with steroids, IVIG, antiseizure medicines, antidepressants and MS drugs
Tap each group of medicines on your current list; its note opens below. Nothing here replaces a pharmacist’s check of your own prescriptions.
Steroids (methylprednisolone, prednisone)
No well-described direct interaction, but high-dose steroids already disturb sleep, mood and blood sugar, and adding THC makes it hard to tell which is causing what. During an acute course, ask the treating team before adding anything.
IVIG and plasma exchange
These are hospital treatments for an active attack. That is not the time to start cannabis; headaches and dizziness after IVIG would also be harder to read.
Antiseizure medicines (clobazam, valproate and others)
CBD is broken down by the liver enzymes CYP3A4 and CYP2C19. On the label of prescription CBD, it raises levels of clobazam’s active product, which deepens sleepiness, and taken with valproate it raises liver enzymes [22]. Any CBD product needs your neurologist’s agreement and, often, blood tests.
Gabapentin and pregabalin
Both cause drowsiness and dizziness on their own. Together with THC or CBD the effects add up, and so does the risk of falls.
Benzodiazepines (clonazepam, lorazepam, diazepam)
Additive sedation and slowed breathing at higher doses. Clobazam, from the antiseizure group, is a benzodiazepine as well and has a direct interaction with CBD.
Antidepressants
Some are processed by the same liver enzymes as CBD, so levels can change; sedating ones add to drowsiness. Tricyclics, sometimes used for nerve pain, can add to a fast heart rate with THC.
Opioid pain medicines
Combined sedation and slowed breathing are the main concern, especially at night. Never change an opioid dose on your own because cannabis seems to help.
MS disease-modifying therapies
Several of these drugs can affect the liver or the heart rhythm, and some are handled by the same liver enzymes as CBD. The neurologist who prescribes your therapy decides whether cannabis fits next to it; more on cannabis and multiple sclerosis.
→ Who should not use cannabis · How the form of use changes things
Who should not use cannabis with encephalomyelitis
Some of these lines are firm, and some mean “only with the specialist who treats you”.
- Children and teenagers. ADEM is most common in childhood, and there is no research on cannabinoids for it at any age. THC affects the developing brain; any decision belongs to the child’s neurologist.
- During an acute attack or a hospital stay. The priority is steroids, IVIG or plasma exchange and close monitoring.
- Pregnancy and breastfeeding. THC reaches the baby, and there is no evidence of safety.
- A history of psychosis or schizophrenia, in you or a close relative. THC can trigger or worsen it.
- Severe balance problems or frequent falls. Dizziness from THC adds to the risk.
- Weak swallowing or breathing. Smoke and vapor go straight to airways that are already struggling.
- Anyone who drives, operates machinery or cares for others alone soon after a dose.
Smoked, vaped, eaten, under the tongue or on the skin: what each form avoids and what stays
Cannabis is not only smoked, and the form changes some risks but not others. Smoke and vapor affect the airways; any form that gets THC into the blood brings the same effects on balance, thinking, sleepiness, the liver and other medicines. The table sorts what each form leaves behind and what it keeps; choosing a form is a conversation with the physician, not a recommendation from this page.
| Form | What it avoids | What stays the same |
|---|---|---|
| Smoking: joints, pipes, bongs | Nothing in particular | Smoke irritates airways; a concern with weak breathing or swallowing. THC effects as below. |
| Vaping: dry-herb vaporizers, oil pens, dabbing | Burning plant material | Hot aerosol still passes the same airways. Concentrates carry high THC. |
| Edibles, drinks, capsules | The airways | Effect starts late and lasts hours; a second helping taken too early is a common cause of taking too much. Passes the liver first. |
| Tinctures and sprays under the tongue | The airways | Absorption varies a lot between people. Same interactions and sedation. |
| Creams and balms | Most effects on the whole body | Act mostly where applied. The CBD cream study was in mice, not a reason to expect relief in people [15]. |
| Transdermal patches | The airways and the stomach | Deliver cannabinoids into the blood, so drowsiness and interactions apply as with any oral form. |
Prescription cannabinoid medicines are a separate category: dronabinol and nabilone (synthetic THC-like drugs) and Epidiolex (purified CBD for certain epilepsies) come from a pharmacy with a prescription, at fixed doses [22] [21]. They are not what a medical marijuana card gives access to, and a card does not replace a prescription for them.
Is medical cannabis worth raising with your neurologist for encephalomyelitis?
It is worth raising when a specific symptom is the problem, such as stiffness, nerve pain or poor sleep, and when you go in knowing how thin the evidence is for your type. In short:
- What is known: in mice and rats with a lab model of MS, cannabinoids made the disease milder.
- What is not: whether that happens in people with ADEM, ME/CFS or autoimmune encephalomyelitis, at what dose, and with what side effects.
- What to discuss: the one symptom you most want help with, your full medicine list, and how you would both judge whether it works.
| Type | Evidence level | Where to read more |
|---|---|---|
| Lab model (EAE) | Animal and cell studies only | The studies on this page |
| MS (encephalomyelitis disseminata) | Studies in people exist | Cannabis and MS |
| ADEM, autoimmune forms | No studies in people | What science does not know |
| ME/CFS | No studies in people | About ME/CFS |
The symptoms people most often ask about each have their own evidence: stiffness and spasticity on cannabis and muscle spasms, nerve pain on cannabis and chronic pain, and sleep on cannabis and insomnia.
Build your question list
Tap the questions you want to ask; your list builds underneath, ready to copy into your phone’s notes.
- Given my type of encephalomyelitis, is there any evidence cannabis could help the symptom that bothers me most?
- Could cannabis interact with any of my current medicines?
- Would THC make my balance or my fall risk worse?
- Could it make my brain fog, thinking or memory worse?
- If we try it, does a CBD-only or a THC-containing product make more sense for me?
- How will we tell after a month whether it is helping, and what do we do if it is not?
- Which side effects mean I should stop and call you?
- Can I drive or work safely on days I use it?
Your list is empty. Tap a question above.
An evaluation makes sense if
Your diagnosis is settled and the acute phase is behind you. One symptom, such as spasms, nerve pain or sleep, keeps limiting your days despite standard care. Your neurologist knows, or you are ready to tell them. You understand that the research for your type is in animals.
It is not the right step if
You have new or worsening symptoms that nobody has assessed. You are in or just out of hospital for an attack. You hope cannabis will replace steroids, immune therapy or an MS medicine. The patient is a child. You are pregnant or have had psychosis.
Does encephalomyelitis qualify for a medical card? Legal status and qualifying rules by state
Encephalomyelitis itself almost never appears by name on a state’s list of qualifying conditions, while multiple sclerosis is listed in many programs. Most people with encephalomyelitis who qualify do so through a listed symptom or a related diagnosis, and the physician matches your records to the exact wording of your state’s list.
Routes through your symptoms
Chronic or nerve pain
Listed in most programs, often as chronic or intractable pain.
Severe muscle spasms
Common after demyelinating disease and named in many lists.
Seizures
Listed nearly everywhere, though seizure medicines need care with CBD.
Multiple sclerosis
Named directly in many programs if your diagnosis is MS.
Debilitating condition clause
Some states let a physician certify a condition that is not listed.
| Topic | What to look for |
|---|---|
| Legal status | Whether the state runs a medical program, and whether recreational sales also exist |
| Qualifying conditions | The exact wording: MS, spasms, chronic pain, seizures, or a debilitating-condition clause |
| Possession limits | How much a registered patient may buy and hold |
| Taxes | Whether patients pay less tax than other buyers |
| Cultivation | Whether patients may grow plants at home |
All of this is set out state by state on medical marijuana laws by state.
Minor patients and caregiver rules
State programs treat minors separately. Where they allow minor patients at all, a parent or legal guardian usually has to consent and register as the patient’s caregiver, and some states require certification from a second physician or limit minors to low-THC products. Many states also let an adult who cannot shop for themselves name a registered caregiver. These rules, forms and fees differ from state to state and are listed on each state’s laws page.
Work, driving, firearms and privacy with a medical card
Driving
A card never makes driving after THC legal. With slowed reactions, vision problems or weakness from encephalomyelitis, THC adds to the impairment you already work around. Do not drive after a dose.
Work and drug tests
Some states protect registered patients from being fired for off-duty use; many do not, and federal jobs and safety-sensitive roles follow federal rules. Check your state’s page and your employer’s policy before you apply.
Firearms
Under federal law, a person who uses marijuana is barred from buying or owning firearms, and the federal purchase form, ATF Form 4473, asks about it directly, whatever your state allows [23].
Privacy
The evaluation is a telemedicine appointment, a medical consultation held online, and its records are protected health information under HIPAA. State patient registries are confidential and not published.
How to get a medical card online, first time or renewal
Everything happens from home: a short application, an appointment with a physician licensed in your state, and the paperwork your state asks for.
1. Apply online
About five minutes: your diagnosis, symptoms and medicines. Keep your neurologist’s letter or MRI report handy.
2. See the physician
About fifteen minutes with a physician licensed in your state. You agree the time together; keep an hour free.
3. Get your recommendation
If approved, it can be ready in as little as fifteen minutes after the appointment, depending on your state. Then register with the state where required.
Across 250 reviews from patients in the states where we are licensed. We do not sort them by score and do not hide the low ones.
- 150,000+patients evaluated – everyone who has been through an appointment with us, in every state where we are licensed
- Since 2017doing only this: online evaluations for medical cannabis programs, and nothing else on the side
Your signed recommendation and appointment history stay in your account, where you can download them again. Renewal works the same way in a shorter form; start it before your current card expires. Price, renewal and what the card covers are explained on how the medical card works, and the fee for your state is shown before you pay. Veterans and patients with low income have their own routes: veterans and low-income patients. The medical content of this page is reviewed by the Dr. Weedy medical team.
Encephalomyelitis and medical cannabis: frequently asked questions
What is autoimmune encephalomyelitis?
It is inflammation of the brain and spinal cord caused by the immune system attacking the nervous system, often with a measurable antibody such as MOG-IgG (MOGAD) or AQP4-IgG (NMOSD). It is diagnosed with MRI, spinal fluid and blood antibody tests, and treated with steroids, plasma exchange and longer-term immune therapy.
What causes encephalomyelitis?
Usually the immune system reacting after an infection, as in ADEM, or an autoimmune disease. Rarely it follows a vaccine. ME/CFS often begins after an infection too, though the reason it persists is still unclear.
Is encephalomyelitis contagious?
No. The inflammation and ME/CFS do not spread between people. The infection that triggered it can be contagious, and mosquito-borne forms spread through bites.
Is myalgic encephalomyelitis a neurological condition?
Yes. The WHO classifies it among diseases of the nervous system, and the US code is G93.32 [3]. It also affects the immune system, energy metabolism and circulation, which is why it is described as multisystem.
Can myalgic encephalomyelitis be cured?
There is no cure or approved drug yet. Many people improve with pacing and treatment of sleep, pain and dizziness, some substantially, but full recovery in adults is uncommon.
Is ME/CFS a disability?
It can be. When symptoms prevent a person from working, ME/CFS can support a disability claim in the United States; the claim rests on documented limits in daily function, so a diagnosis from a physician and records of PEM matter.
What is the ICD-10 code for encephalomyelitis?
It depends on the type: G04.00 to G04.02 for ADEM, G04.81 for other named forms, G04.90 when unspecified, G93.32 for ME/CFS, and G35.A to G35.D for multiple sclerosis since October 2025 [3].
Can CBD help encephalomyelitis?
Is encephalomyelitis a qualifying condition for medical marijuana?
Rarely by name. Patients usually qualify through MS, chronic pain, severe muscle spasms, seizures or a debilitating-condition clause, depending on the state’s list. The physician checks your records against that list at the evaluation.
What is progressive encephalomyelitis with rigidity and myoclonus?
PERM is a rare autoimmune disease in the stiff person spectrum, often with antibodies against the glycine receptor. It causes muscle stiffness, painful spasms, sudden jerks and brainstem symptoms, and is treated with immune therapy and medicines that relax muscles.
Are hemp CBD or delta-8 products the same as state-program cannabis?
No. Hemp-derived CBD and delta-8 products are sold outside medical programs, with uneven labeling and testing. State-program products are tested and labeled for THC and CBD content under state rules, and a medical card is what gives you access to them.
More research on cannabis and encephalomyelitis
This page cites a selection of studies. Our research library holds every study we track on cannabis and encephalomyelitis, from laboratory work to clinical trials, and lets you filter them by cannabinoid, study type and year.
- studies
- 86
- in people
- 44
- clinical trials
- 0
Share your experience
References
23 sources
- 1. National Institute of Neurological Disorders and Stroke. Acute Disseminated Encephalomyelitis. 2024.
- 2. National Institute of Neurological Disorders and Stroke. Encephalitis. 2024.
- 3. Centers for Medicare & Medicaid Services. ICD-10 Codes, FY 2026 ICD-10-CM. 2025.
- 4. Centers for Disease Control and Prevention. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). 2024.
- 5. National Multiple Sclerosis Society. What Is MS?. 2025.
- 6. Centers for Disease Control and Prevention. About Eastern Equine Encephalitis Virus. 2024.
- 7. ASPCA Animal Poison Control Center. Marijuana. 2024.
- 8. Institute of Medicine (National Academies). Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. 2015.
- 9. Encephalitis International. Information and support for people affected by encephalitis. 2025.
- 10. The CB1 Receptor Differentially Regulates IFN-γ Production In Vitro and in Experimental Autoimmune Encephalomyelitis. DOI: 10.1089/can.2020.0046 PMID: 33998867
- 11. Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS. DOI: 10.1016/j.cellimm.2013.11.002 PMID: 24342422
- 12. CBD Suppression of EAE Is Correlated with Early Inhibition of Splenic IFN-γ + CD8+ T Cells and Modest Inhibition of Neuroinflammation. DOI: 10.1007/s11481-020-09917-8 PMID: 32440886
- 13. Cannabidiol Regulates Gene Expression in Encephalitogenic T cells Using Histone Methylation and noncoding RNA during Experimental Autoimmune Encephalomyelitis. DOI: 10.1038/s41598-019-52362-8 PMID: 31673072
- 14. Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome. DOI: 10.1016/j.bbi.2019.07.028 PMID: 31356922
- 15. A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis. DOI: 10.1186/s40199-015-0131-8 PMID: 26489494
- 16. A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis. DOI: 10.1371/journal.pone.0094733 PMID: 24727978
- 17. The Effect of Exercise Training and Royal Jelly on Hippocampal Cannabinoid-1-Receptors and Pain Threshold in Experimental Autoimmune Encephalomyelitis in Rats as Animal Model of Multiple Sclerosis. DOI: 10.3390/nu14194119 PMID: 36235771
- 18. Crotalphine Attenuates Pain and Neuroinflammation Induced by Experimental Autoimmune Encephalomyelitis in Mice. DOI: 10.3390/toxins13110827 PMID: 34822611
- 19. A co-ultramicronized palmitoylethanolamide/luteolin composite mitigates clinical score and disease-relevant molecular markers in a mouse model of experimental autoimmune encephalomyelitis. DOI: 10.1186/s12974-019-1514-4 PMID: 31221190
- 20. Mir223 restrains autophagy and promotes CNS inflammation by targeting ATG16L1. DOI: 10.1080/15548627.2018.1522467 PMID: 30208760
- 21. U.S. Food and Drug Administration. Marinol (dronabinol) prescribing information. 2017.
- 22. U.S. Food and Drug Administration. Epidiolex (cannabidiol) prescribing information. 2018.
- 23. Bureau of Alcohol, Tobacco, Firearms and Explosives. ATF Form 4473, Firearms Transaction Record. 2023.















